Skip to main content
OpenTrials

Clinical trial condition

Recurrent Prostate Carcinoma

Explore clinical trials studying Recurrent Prostate Carcinoma. Study availability and eligibility vary by location and protocol.

53 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Prostate Carcinoma trial results

Completed

Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01576172

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 14 locations
View Trial Details
Completed

Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide

NCT02228265

Conditions
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Genital Diseases, +13 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

NCT01026623

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

Tivantinib in Treating Patients With Metastatic Prostate Cancer

NCT01519414

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Michael Reese Hospital Chicago, Illinois, United States
View all 20 locations
View Trial Details

Related conditions